Ana Rogovic serves as the VP of International Affiliates for DACH & Nordics and Managing Director for Amicus Therapeutics in Germany. Her career is marked by leadership roles in specialized pharmaceuticals at Amgen and Bristol-Myers Squibb. She holds masters degrees in Political Science and International Relations.
She is a passionate advocate for patients with rare diseases, frequently engaging in awareness campaigns. Her public statements emphasize the need for equity in healthcare, better access to therapies, and reducing the daily burden on patients and their families, reflecting a deep commitment to the community her company serves.
Ana represents her company in federal health committee hearings, directly advocating for patient access to new and innovative treatments for rare conditions.
Read the full overview →While they don't hesitate to ask questions, they are generally risk-averse and tend to be late adopters. They are more likely than others to negotiate on pricing and terms. They generally do not appreciate an overfriendly approach and prefer to stay to-the-point.
Calculativeness (C) reflects the degree to which a person is likely to be cautious, systematic and analytical. Those scoring high tend to emphasise quality and accuracy.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.